|
1
|
Barra WF, Moreira FC, Pereira Cruz AM,
Khayat AS, Calcagno DQ, Carneiro Dos Santos NP, Mascarenhas Junior
RW, Thomaz Araújo TM, Ishak G, Demachki S and Rodríguez Burbano RM:
GEJ cancers: Gastric or esophageal tumors? searching for the answer
according to molecular identity. Oncotarget. 8:104286–104294. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cunningham SC, Kamangar F, Kim MP, Hammoud
S, Haque R, Maitra A, Montgomery E, Heitmiller RE, Choti MA,
Lillemoe KD, et al: Survival after gastric adenocarcinoma
resection: Eighteen-year experience at a single institutuion. J
Gastrointest Surg. 9:718–725. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hwang JH: Understanding gastric cancer
risk factors: We need to close the gap. Gut Liver. 12:1–2. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng PL, Zhou XY, Yi GD, Chen PF, Wang F
and Dong WG: Identification of a novel gene pairs signature in the
prognosis of gastric cancer. Cancer Med. 7:344–350. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nienhüser H and Schmidt T: Angiogenesis
and anti-angiogenic therapy in gastric cancer. Int J Mol Sci.
19:E432017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fan L, Tan B, Li Y, Zhao Q, Yuan H, Liu Y,
Wang D and Zhang Z: Upregulation of miR185 promotes apoptosis of
the human gastric cancer cell line MGC803. Mol Med Rep.
17:3115–3122. 2018.PubMed/NCBI
|
|
7
|
Huang J, He Y, McLeod HL, Xie Y, Xiao D,
Hu H, Chen P, Shen L, Zeng S, Yin X, et al: miR-302b inhibits
tumorigenesis by targeting EphA2 via Wnt/β-catenin/EMT signaling
cascade in gastric cancer. BMC Cancer. 17:8862017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang T, Zhou Y, Zhang J, Wong CC, Li W,
Kwan JSH, Yang R, Chan AKY, Dong Y, Wu F, et al: SRGAP1, a crucial
target of miR-340 and miR-124, functions as a potential oncogene in
gastric tumorigenesis. Oncogene. 37:1159–117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qu Y, Zhang H, Sun W, Han Y, Li S, Qu Y,
Ying G and Ba Y: MiR-155 promotes gastric cancer growth and
invasion by negatively regulating transforming growth factor β
receptor 2. Cancer Sci. 109:618–62. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shrestha S, Yang CD, Hong HC, Chou CH, Tai
CS, Chiew MY, Chen WL, Weng SL, Chen CC, Chang YA, et al: :
Integrated MicroRNA-mRNA analysis reveals miR-204 inhibits cell
proliferation in gastric cancer by targeting CKS1BCXCL1GPRC5A. Int
J Mol Sci. 19:E872017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang T, Ren Y, Liu R, Ma J, Shi Y, Zhang L
and Bu R: miR-195-5p suppresses the proliferation, migration, and
invasion of oral squamous cell carcinoma by targeting TRIM14.
Biomed Res Int. 2017:73781482017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu S, Jing L, Yin XR, Wang MC, Chen YM,
Guo Y, Nan KJ and Han LL: MiR-195 suppresses the metastasis and
epithelial-mesenchymal transition of hepatocellular carcinoma by
inhibiting YAP. Oncotarget. 8:99757–99771. 2017.PubMed/NCBI
|
|
13
|
He B, Yan F and Wu C: Overexpressed
miR-195 attenuated immune escape of diffuse large B-cell lymphoma
by targeting PD-L1. Biomed Pharmacother. 98:95–101. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong Z, Zhang R and Qi H: Diagnostic and
prognostic relevance of serum miR-195 in pediatric acute myeloid
leukemia. Cancer Biomark. 21:269–275. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Liu J, Wang L, Yang X and Liu X:
MicroRNA195 inhibits cell proliferation, migration and invasion in
laryngeal squamous cell carcinoma by targeting ROCK1. Mol Med Rep.
16:7154–7162. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qattan A, Intabli H, Alkhayal W, Eltabache
C, Tweigieri T and Amer SB: Robust expression of tumor suppressor
miRNA's let-7 and miR-195 detected in plasma of Saudi female breast
cancer patients. BMC Cancer. 17:7992017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fléjou JF: WHO classification of digestive
tumors: The fourth edition. Ann Pathol. 31 Suppl 5:S27–S31.
2011.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, Macleod RA, Master JR, Nakamura Y, Reid YA,
Reddel RR and Freshney RI: Check your cultures! A list of
cross-contaminated or misidentified cell lines. Int J Cancer.
127:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Tan BB, Zhao Q, Fan LQ, Liu Y and
Wang D: Regulatory mechanism of ZNF139 in multi-drug resistance of
gastric cancer cells. Mol Biol Rep. 41:3603–3610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nie HF, Li Y, Li ZX, Mu JX and Wang JS:
Effects of ZNF139 on gastric cancer cells and mice with gastric
tumors. Oncol Lett. 12:2550–2554. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu W, Yang Z and Lu N: Molecular targeted
therapy for the treatment of gastric cancer. J Exp Clin Cancer Res.
35:12016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen S, Wang L, Yao X, Chen H, Xu C, Tong
L, Shah A, Huang T, Chen G, Chen J, et al: miR-195-5p is critical
in REGγ-mediated regulation of wnt/β-catenin pathway in renal cell
carcinoma. Oncotarget. 8:63986–64000. 2017.PubMed/NCBI
|
|
24
|
Stefan K, Schmitt SM and Wiese M:
9-Deazapurines as broad-spectrum inhibitors of the ABC transport
proteins P-glycoprotein, multidrug resistance-associated protein 1,
and breast cancer resistance protein. J Med Chem. 60:8758–8780.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Wang X, Zhao H, Liang B and Du Q:
Clusterin confers resistance to TNF-alpha-induced apoptosis in
breast cancer cells through NF-kappaB activation and Bcl-2
overexpression. J Chemother. 24:348–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tomek M, Akiyama T and Dass CR: Role of
Bcl-2 in tumour cell survival and implications for pharmacotherapy.
J Pharm Pharmacol. 64:1695–1702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jen J and Wang YC: Zinc finger proteins in
cancer progression. J Biomed Sci. 23:532016. View Article : Google Scholar : PubMed/NCBI
|
